Glutaraldehyde

CAS RN: 111-30-8

Laboratory

A) Monitor fluid and electrolytes in patients that develop significant diarrhea and/or vomiting following exposure.
B) Monitor vital signs following an oral exposure.
C) In rare cases, monitor CBC for evidence of bleeding in patients that develop gastrointestinal bleeding. If respiratory tract irritation or respiratory insufficiency are clinically evident, consider monitoring pulse oximetry, arterial blood gases, chest x-ray, and pulmonary function tests.
D) Obtain blood gases and/or bicarbonate levels in patients at risk to develop acidosis.
E) Monitor renal function and liver enzymes as indicated in symptomatic patients.
F) Pulmonary function tests may be indicated in patients that develop respiratory symptoms following chronic occupational exposure.
Find more information on this substance at: PubChem, PubMed